Skip to main content

Table 1 Summary of Neuroblastoma Endpoints

From: HetEnc: a deep learning predictive model for multi-type biological dataset

Endpoint

FAV

OS_All

OS_HR

Full description

Neuroblastoma Favorable Prognosis

Overall Survival

Survival in High Risk patients

Sample size (Train/Test)

136/136

249/249

86/90

Train set prevalence

45/91 (0.669)

51/198 (0.795)

43/43 (0.500)

Test set prevalence

46/90 (0.662)

54/195 (0.783)

49/41 (0.544)

Predicting difficulty

(Zhang, et al., 2015)

Easy

Medium

Hard